Reply from the authors: The race for the second best…continues—The no-touch saphenous vein versus the radial artery

Abstract

We thank Dashwood and colleagues 1 for their reply to our commentary regarding the use of the radial artery (RA) and no-touch saphenous vein graft (NT-SVG) in patients undergoing coronary artery bypass grafting surgery. 2 Our commentary was predicated on the recently published 8-year patency results of a single-center randomized controlled trial comparing the RA with the NT-SVG by Dreifaldt and colleagues. 3 We agree that NT-SVG has excellent potential as